Latest Breaking News On - ஹமிட் அயோடிஜி - Page 1 : comparemela.com

with agency report Pfizer and BioNTech have struck a deal for South Africa’s Biovac Institute to help manufacture around 100 million doses a year of their COVID-19 vaccine for the African Union. Reuters reported that the firms disclosed this yesterday. The deal is to “fill and finish” the vaccine, the final stages of manufacturing where the product is processed and put into vials. It does not cover the complicated processes of mRNA drug substance production, which Pfizer and BioNTech will do at their own facilities in Europe, the report explained. The agreement comes as Pfizer and BioNTech try to sway World Trade Organisation’s (WTO) members from supporting a waiver on some intellectual property rights for COVID-19 vaccines.

South africaSouth africanHamid ayodejiAlbert bourlaMorena makhoanaCyril ramaphosaAfrican unionWorld trade organisationAfrica biovac instituteWorld health organisationBiovac instituteCape town based biovacAfrican president cyril ramaphosaஹமிட் அயோடிஜிஉலகம் வர்த்தகம் ஆர்கநைஸேஶந்உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்